Publications

Probity Medical Research has compiled journals, articles and presentations for your personal review. Please use the search features below to find an article.

 

If you would like to request an article for personal review please complete the registration form. These publications are for personal use only and cannot be distributed. 

Register

 

Already granted access to an article?  

Login

 

If you cannot find the article you are looking for please contact Probity Medical Research. 

Journals, Articles and Presentations

Found 21 matches.
Page:
1
Refine your search to narrow the results.

ESPRIT: Interim Results From a 10-year Postmarketing Surveillance Registry of Adalimumab Treatment for Moderate to Severe Psoriasis

Presented at the 20th Congress of the European Academy of Dermatology and Venereology, Lisbon, Portugal, 20–24 October 2011

Condition
Psoriasis
Author
Francisco Kerdel, Diamant Tha├ži, Andrew Blauvelt, William Abramovits, Richard G. Langley, Yves Poulin, Kim Papp, Knud Kragballe, Jonathan Barker, Ke Chen, Orin Goldblum
Year
2011
Register & Request Access

Short- and Long-term Briakinumab Efficacy in Moderate to Severe Psoriasis Patients With Prior TNF Antagonist Exposure: Subanalysis of a 52-Week Phase III Trial and Open-Label Extension

Presented at the 20th Congress of the European Academy of Dermatology and Venereology, Lisbon, Portugal, 20-24 October 2011

Condition
Psoriasis
Author
Kim A Papp, Michele O Heckaman, Joaquin Valdes
Year
2011
Register & Request Access

Further Validation of the Safe Psoriasis Control Metric: A Composite Measure of Benefit and Risk in Psoriasis Treatment

Presented at the 20th Congress of the European Academy of Dermatology and Venereology, Lisbon, Portugal, 20-24 October 2011

Condition
Psoriasis
Author
Kim Papp, Yanjun Bao, James Signorovitch, Alex Trahey, Murali Sundaram, Parvez M Mulani
Year
2011
Register & Request Access

Benefit-Risk Outcomes With Adalimumab Versus Methotrexate for Moderate to Severe Psoriasis During the First Year of Treatment

Presented at the 20th Congress of the European Academy of Dermatology and Venereology, Lisbon, Portugal, 20-24 October 2011

Condition
Psoriasis
Author
Kim Papp, Yanjun Bao, James Signorovitch, Kejal Parikh, Murali Sundaram, Parvez M Mulani
Year
2011
Register & Request Access

Efficacy of Adalimumab in Patients with Moderate to Severe Psoriasis and a <PASI 75 Response Following 16 Weeks of Treatment

Presented at the 20th Fall European Academy of Dermatology and Venereology, Lisbon, Portugal October 20-24, 2011

Condition
Psoriasis
Author
K Gordon, K Papp, Y Poulin, Y Gu, and O Goldblum
Year
2011
Register & Request Access

A 52-Week Trial Comparing Briakinumab with Methotrexate in Patients with Psoriasis

The New England Journal of Medicine 2011 Oct 27; 365(17):1586-96.

Journal
The New England Journal of Medicine (NEJM)
PubMed ID
22029980
Condition
Psoriasis
Author
Reich K, Langley R, Papp K, Ortonne JP, Unnebrink K, Kaul M, Valdes J
Year
2011
Register & Request Access

Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults

Journal of American Academy of Dermatology 2011 Nov 17; [Epub ahead of print]

Journal
Journal of American Acadamy of Dermatology (JAAD)
PubMed ID
22101215
Condition
Seborrheic Dermatitis
Author
Kim A. Papp, Alexine Papp, Betty Dahmer, Christina Clark
Year
2011
Register & Request Access

Efficacy and safety of adalimumab when added to inadequate therapy for the treatment of psoriasis: results of PRIDE, an open-label, multicentre, phase IIIb study

Journal of the European Academy of Dermatology and Venereology 2011 Oct 25. [Epub ahead of print]

Journal
Journal of the European Academy of Dermatology and Venereology (JEADV)
PubMed ID
22023702
Condition
Psoriasis
Author
K. Papp, V. Ho, H.D. Teixeira, B. Guerette, K. Chen, C. Lynde
Year
2011
Register & Request Access

Cost-effectiveness evaluation of clobetasol propionate shampoo (CPS) maintenance in patients with moderate scalp psoriasis a Pan-European analysis

Journal of the European Academy of Dermatology and Venereology 2011 Oct 27. [Epub ahead of print]

Journal
Journal of the European Academy of Dermatology and Venereology (JEADV)
PubMed ID
22032474
Condition
Psoriasis
Author
K Papp, Y Poulin, K Barber, C Lynde, JC Prinz, M Berg, N Kerrouche, VP Rives
Year
2011
Register & Request Access

Oral Apremilast is Active in the Treatment of Moderate to Severe Plaque Psoriasis

Presented at the 69th Annual Meeting of the American Academy of Dermatology, New Orleans, Los Angeles, February 4-8 2011

Condition
Psoriasis
Author
K. Papp, A. Hu, R.M. Day
Year
2011
Register & Request Access
Page:
1

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.

Login